Effect of Antimicrobial Peptides HNP-1 and hBD-1 on Staphylococcus aureus Clinical Strains in vitro and in vivo
Preprint
Abstract
The aims of this study were: (1) To investigate the activity of recombinant AMPs HNP-1 and hBD-1 in combination with cefotaxime against Staphylococcus aureus clinical strains (MSSA and MRSA) in vitro using checkerboard method; (2) To investigate the activity of HNP-1 and hBD-1 encapsulated in silicon nanoparticles (niosomes) in the treatment of MRSA-infected wound in rats. For this S. aureus clinical strains (MSSA and MRSA) were isolated from patients with diabetic foot infection. Cefotaxime, recombinant HNP-1 and hBD-1 (in all possible combinations with each other) were used for testing by the checkerboard method. Two niosomal topical gels with HNP-1/hBD-1 were prepared to treat MRSA-infected wounds in rats. Gels were administered once a day, the control group – without treatment. Wound healing rate was calculated on the 4th, 9th and 16th days of the experiment and compared using one-way ANOVA with Bonferroni correction. MIC of HNP-1 for MSSA and MRSA was the same – 1 mg/L. MIC of hBD-1 for MSSA and MRSA was also the same – 0.5 mg/L. Topical gels with niosomal HNP-1 (or hBD-1) showed a significantly faster wound healing in comparison with the control. The data obtained open up prospects for use of AMPs encapsulated in silica nanoparticles for the development of new antibiotics.Keywords
All Related Versions
- Published version: Fundamental & Clinical Pharmacology, 34 (1), 102.
This publication has 24 references indexed in Scilit:
- Novel Anti-bacterial Activities of β-defensin 1 in Human Platelets: Suppression of Pathogen Growth and Signaling of Neutrophil Extracellular Trap FormationPLOS Pathogens, 2011
- Comparison of the Broth Microdilution (BMD) Method of the European Committee on Antimicrobial Susceptibility Testing with the 24-Hour CLSI BMD Method for Testing Susceptibility of Candida Species to Fluconazole, Posaconazole, and Voriconazole by Use of Epidemiological Cutoff ValuesJournal of Clinical Microbiology, 2011
- Injury Is a Major Inducer of Epidermal Innate Immune Responses during Wound HealingJournal of Investigative Dermatology, 2010
- Functional interaction of human neutrophil peptide‐1 with the cell wall precursor lipid IIFEBS Letters, 2010
- Synergistic Interaction between Silver Nanoparticles and Membrane-Permeabilizing Antimicrobial PeptidesAntimicrobial Agents and Chemotherapy, 2009
- A global view of antibiotic resistanceFEMS Microbiology Reviews, 2009
- Human β-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2Proceedings of the National Academy of Sciences, 2007
- Human β-Defensin 2 Induces a Vigorous Cytokine Response in Peripheral Blood Mononuclear CellsAntimicrobial Agents and Chemotherapy, 2006
- Synergy Tests by E Test and Checkerboard Methods of Antimicrobial Combinations against Brucella melitensisJournal of Clinical Microbiology, 2005
- Synergy, antagonism, and what the chequerboard puts between themJournal of Antimicrobial Chemotherapy, 2003